Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Clinical trial NCT00182533 · TERMINATED

Trial details

NCT number: NCT00182533
Sponsor: Hamilton Health Sciences Corporation
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Phobia, Social Panic Disorder Agoraphobia Obsessive-Compulsive Disorder Anxiety Disorders Major Depressive Disorder

Start date: 2002-07-01
Primary completion: 2018-01-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.